Identification of a homogeneous class of beta 2-adrenoceptors in human platelets by (-)-125I-iodopindolol binding
- PMID: 2866204
Identification of a homogeneous class of beta 2-adrenoceptors in human platelets by (-)-125I-iodopindolol binding
Abstract
The highly specific beta-adrenoceptor radioligand (-)-125I-iodopindolol (IPIN) was used to label in membranes from human platelets beta-adrenoceptors. Binding of IPIN was at 25 degrees C saturable (Bmax = 7.4 +/- 2.5 fmoles bound/mg protein, N = 10) of high affinity (KD-value = 34.8 +/- 3.3 pM, N = 10), rapid and reversible. beta-Adrenoceptor antagonists inhibited binding of IPIN with monophasic displacement curves and pseudo Hill coefficients (nH) not significantly different from 1.0. The beta 2-selective antagonist ICI 118,551 was much more potent in inhibiting IPIN binding than the beta 1-selective antagonist bisoprolol. IPIN binding was stereospecific as indicated by the 100-times greater potencies of (-)-alprenolol and (-)-isoprenaline in inhibiting binding than their (+)-isomers. beta-Adrenoceptor agonists inhibited binding with slightly shallow displacement curves and nH-values of 0.85-0.88; the order of potency was: isoprenaline greater than adrenaline greater than noradrenaline. These results demonstrate that IPIN labels (in human platelet membranes with high affinity) a homogeneous population of beta 2-adrenoceptors with low capacity.
Similar articles
-
(-)-[125I]-iodopindolol, a new highly selective radioiodinated beta-adrenergic receptor antagonist: measurement of beta-receptors on intact rat astrocytoma cells.J Cyclic Nucleotide Res. 1980;6(4):297-307. J Cyclic Nucleotide Res. 1980. PMID: 6110683
-
Preferential reduction of binding of 125I-iodopindolol to beta-1 adrenoceptors in the amygdala of rat after antidepressant treatments.J Pharmacol Exp Ther. 1991 May;257(2):681-90. J Pharmacol Exp Ther. 1991. PMID: 1674532
-
Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists.Mol Pharmacol. 1984 Mar;25(2):209-18. Mol Pharmacol. 1984. PMID: 6142414
-
Coexistence of beta 1- and beta 2-adrenoceptors in human right atrium. Direct identification by (+/-)-[125I]iodocyanopindolol binding.Circ Res. 1983 Dec;53(6):752-8. doi: 10.1161/01.res.53.6.752. Circ Res. 1983. PMID: 6139182
-
Characterisation of human platelet adrenoceptors.Adv Exp Med Biol. 1985;192:97-108. doi: 10.1007/978-1-4615-9442-0_8. Adv Exp Med Biol. 1985. PMID: 2871708 Review. No abstract available.
Cited by
-
Does treatment with beta-adrenoceptor antagonists in vivo alter human adenylate cyclase responsiveness in vitro?Br J Clin Pharmacol. 1991 Jul;32(1):105-9. doi: 10.1111/j.1365-2125.1991.tb05620.x. Br J Clin Pharmacol. 1991. PMID: 1679657 Free PMC article.
-
Is the human platelet beta 2 adrenoceptor coupled to adenylate cyclase?Naunyn Schmiedebergs Arch Pharmacol. 1988 Feb;337(2):238-40. doi: 10.1007/BF00169254. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 2835692
-
Human platelet beta 2-adrenoceptors: agonist-induced internalisation and down-regulation in intact cells.Br J Pharmacol. 1987 Nov;92(3):587-96. doi: 10.1111/j.1476-5381.1987.tb11360.x. Br J Pharmacol. 1987. PMID: 2892553 Free PMC article.